Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEHYW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,990
Award facts
- Contract value 100% obligated
- $6,989.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,989.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on October 31, 2025, represents one of numerous pharmaceutical supply orders awarded to DMS under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Logistics Agency acquisition strategy that establishes multiple regional prime vendor contractors to support Department of Defense medical supply needs. The delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. No subcontractors have been identified in the award documentation.
DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract under the PPV-G GEN V program (contract SPE2DR) with a $499.999 billion ceiling value and completion date of December 31, 2036, positioning the company as a critical pharmaceutical supplier for military healthcare facilities worldwide. The contractor's product portfolio encompasses branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support the diverse healthcare requirements of the federal military medical system. The company's established performance across multiple delivery orders demonstrates its capability to fulfill specialized pharmaceutical needs across therapeutic categories ranging from oncology treatments and immunosuppressants to emergency medications and routine pharmaceuticals.
Quick answers
Who was awarded contract SPE2DU26FEHYW?
SPE2DU26FEHYW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DU26FEHYW worth?
The government has obligated $6,990 on SPE2DU26FEHYW.
Is contract SPE2DU26FEHYW an order under another contract?
Yes. SPE2DU26FEHYW is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHYW competed?
The extent of competition for SPE2DU26FEHYW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award